151 related articles for article (PubMed ID: 6710076)
1. Are all gliadins toxic in coeliac disease? An in vitro study of alpha, beta, gamma, and w gliadins.
Howdle PD; Ciclitira PJ; Simpson FG; Losowsky MS
Scand J Gastroenterol; 1984 Jan; 19(1):41-7. PubMed ID: 6710076
[TBL] [Abstract][Full Text] [Related]
2. [Decrease of the cytotoxicity of gliadin fractions in the development of celiac disease. Organotypic culture study].
Arnaud-Battandier F; Magazzu G; Schmitz J; Jos J; Rey J
Arch Fr Pediatr; 1985 Mar; 42(3):245-8. PubMed ID: 4004485
[TBL] [Abstract][Full Text] [Related]
3. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease.
de Ritis G; Auricchio S; Jones HW; Lew EJ; Bernardin JE; Kasarda DD
Gastroenterology; 1988 Jan; 94(1):41-9. PubMed ID: 3335296
[TBL] [Abstract][Full Text] [Related]
4. Toxicity of different wheat gliadins in coeliac disease.
Wieser H; Springer G; Belitz HD; Ashkenazi A; Idar D
Z Lebensm Unters Forsch; 1982; 175(5):321-6. PubMed ID: 6758408
[TBL] [Abstract][Full Text] [Related]
5. Clinical testing of gliadin fractions in coeliac patients.
Ciclitira PJ; Evans DJ; Fagg NL; Lennox ES; Dowling RH
Clin Sci (Lond); 1984 Mar; 66(3):357-64. PubMed ID: 6692666
[TBL] [Abstract][Full Text] [Related]
6. Intestinal mucosa of celiacs in remission is unable to abolish toxicity of gliadin peptides on in vitro developing fetal rat intestine and cultured atrophic celiac mucosa.
Cornell HJ; Auricchio RS; De Ritis G; De Vincenzi M; Maiuri L; Raia V; Silano V
Pediatr Res; 1988 Aug; 24(2):233-7. PubMed ID: 3186334
[TBL] [Abstract][Full Text] [Related]
7. In vitro pathogenetic studies of coeliac disease. Effects of protein digests on coeliac intestinal biopsy specimens maintained in culture for 48 hours.
Jos J; Lenoir G; Ritis G D; Rey J
Scand J Gastroenterol; 1975; 10(2):121-8. PubMed ID: 1091964
[TBL] [Abstract][Full Text] [Related]
8. [In vitro intestinal cytotoxicity of various fractions from gliadin or cows's milk proteins in children: quantitative assessment by a morphometric method].
Olives JP; Schmitz J; Jos J; de Tand MF; Rey J
Gastroenterol Clin Biol; 1982; 6(6-7):557-62. PubMed ID: 7117767
[No Abstract] [Full Text] [Related]
9. Wheat deficient in gliadins: promising tool for treatment of coeliac disease.
Frisoni M; Corazza GR; Lafiandra D; De Ambrogio E; Filipponi C; Bonvicini F; Borasio E; Porceddu E; Gasbarrini G
Gut; 1995 Mar; 36(3):375-8. PubMed ID: 7698695
[TBL] [Abstract][Full Text] [Related]
10. Gamma-type gliadins cause secretion of prostaglandin E2 in patients with coeliac disease.
Friis S; Anthonsen D; Norén O; Sjöström H
Clin Chim Acta; 1994 Dec; 231(2):173-83. PubMed ID: 7889599
[TBL] [Abstract][Full Text] [Related]
11. Characterizing one of the DQ2 candidate epitopes in coeliac disease: A-gliadin 51-70 toxicity assessed using an organ culture system.
Martucci S; Fraser JS; Biagi F; Corazza GR; Ciclitira PJ; Ellis HJ
Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1293-8. PubMed ID: 14624152
[TBL] [Abstract][Full Text] [Related]
12. Lack of intestinal mucosal toxicity of Triticum monococcum in celiac disease patients.
Pizzuti D; Buda A; D'Odorico A; D'Incà R; Chiarelli S; Curioni A; Martines D
Scand J Gastroenterol; 2006 Nov; 41(11):1305-11. PubMed ID: 17060124
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a gluten free product containing wheat gliadin in patients with coeliac disease.
Ciclitira PJ; Ellis HJ; Fagg NL
Br Med J (Clin Res Ed); 1984 Jul; 289(6437):83. PubMed ID: 6428688
[No Abstract] [Full Text] [Related]
14. Oral administration of Bifidobacterium longum CECT 7347 modulates jejunal proteome in an in vivo gliadin-induced enteropathy animal model.
Olivares M; Laparra M; Sanz Y
J Proteomics; 2012 Dec; 77():310-20. PubMed ID: 23023000
[TBL] [Abstract][Full Text] [Related]
15. Effects of gliadin peptides B1-B4 in celiac disease. I. Organ culture studies.
Stallmach A; Belitz HD; Gellermann B; Schäfer H; Wieser H; Stern M
J Pediatr Gastroenterol Nutr; 1987; 6(3):335-40. PubMed ID: 3430242
[TBL] [Abstract][Full Text] [Related]
16. Effect of alpha-gliadin-derived peptides from bread and durum wheat on K562(S) cells.
Dessi M; De Vincenzi M; Maialetti F; Mancini E
Ital J Gastroenterol; 1992 Sep; 24(7):397-9. PubMed ID: 1392022
[TBL] [Abstract][Full Text] [Related]
17. In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture.
Shidrawi RG; Day P; Przemioslo R; Ellis HJ; Nelufer JM; Ciclitira PJ
Scand J Gastroenterol; 1995 Aug; 30(8):758-63. PubMed ID: 7481543
[TBL] [Abstract][Full Text] [Related]
18. An in vitro animal model for the study of cereal components toxic in celiac disease.
Auricchio S; Cardelli M; De Ritis G; De Vincenzi M; Latte F; Silano V
Pediatr Res; 1984 Dec; 18(12):1372-8. PubMed ID: 6441144
[TBL] [Abstract][Full Text] [Related]
19. The use of extended amino acid motifs for focussing on toxic peptides in coeliac disease.
McLachlan A; Cullis PG; Cornell HJ
J Biochem Mol Biol Biophys; 2002 Oct; 6(5):319-24. PubMed ID: 12385967
[TBL] [Abstract][Full Text] [Related]
20. The toxic fraction of gliadin digests in coeliac disease. Isolation by chromatography on Biogel P-10.
Jos J; Charbonnier L; Mossé J; Olives JP; de Tand MF; Rey J
Clin Chim Acta; 1982 Mar; 119(3):263-74. PubMed ID: 6802520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
